share_log

Further Weakness as Qingdao Kingking Applied Chemistry (SZSE:002094) Drops 16% This Week, Taking Five-year Losses to 34%

Further Weakness as Qingdao Kingking Applied Chemistry (SZSE:002094) Drops 16% This Week, Taking Five-year Losses to 34%

青島金王應用化學(SZSE:002094)本週下跌16%,五年跌幅達到34%,進一步疲軟
Simply Wall St ·  02/02 02:03

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the main game is to find enough winners to more than offset the losers At this point some shareholders may be questioning their investment in Qingdao Kingking Applied Chemistry Co., Ltd. (SZSE:002094), since the last five years saw the share price fall 34%. And it's not just long term holders hurting, because the stock is down 33% in the last year. Even worse, it's down 23% in about a month, which isn't fun at all. However, we note the price may have been impacted by the broader market, which is down 13% in the same time period.

爲了證明選擇個股的努力是合理的,值得努力超過市場指數基金的回報。但主要的遊戲是找到足夠的贏家來抵消輸家。此時,一些股東可能會質疑他們對青島金王應用化學有限公司(SZSE:002094)的投資,因爲在過去五年中,股價下跌了34%。而且,受傷害的不僅僅是長揸者,因爲該股去年下跌了33%。更糟糕的是,它在大約一個月內下降了23%,這一點都不好玩。但是,我們注意到價格可能受到大盤的影響,同期下跌了13%。

With the stock having lost 16% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.

由於該股在過去一週下跌了16%,值得一看業務表現,看看是否存在任何危險信號。

Because Qingdao Kingking Applied Chemistry made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

由於青島金王應用化學在過去十二個月中出現虧損,我們認爲至少目前市場可能更加關注收入和收入增長。無利可圖的公司的股東通常期望強勁的收入增長。這是因爲快速的收入增長可以很容易地推斷出來預測利潤,通常規模相當大。

In the last five years Qingdao Kingking Applied Chemistry saw its revenue shrink by 17% per year. That's definitely a weaker result than most pre-profit companies report. On the face of it we'd posit the share price fall of 6% compound, over five years is well justified by the fundamental deterioration. We doubt many shareholders are delighted with this share price performance. It is possible for businesses to bounce back but as Buffett says, 'turnarounds seldom turn'.

在過去的五年中,青島金王應用化學的收入每年減少17%。這絕對比大多數盈利前公司報告的結果要差。從表面上看,我們認爲股價在五年內複合下跌6%,這完全是基本面惡化所證明的。我們懷疑許多股東對這種股價表現感到滿意。企業有可能反彈,但正如巴菲特所說,“轉機很少會轉機”。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下圖顯示了收入和收入隨時間推移的跟蹤情況(如果您點擊圖片,可以看到更多細節)。

earnings-and-revenue-growth
SZSE:002094 Earnings and Revenue Growth February 2nd 2024
SZSE: 002094 2024 年 2 月 2 日收益和收入增長

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

資產負債表的強度至關重要。可能值得一看我們關於其財務狀況如何隨着時間的推移而變化的免費報告。

A Different Perspective

不同的視角

While the broader market lost about 25% in the twelve months, Qingdao Kingking Applied Chemistry shareholders did even worse, losing 33%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 6% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 1 warning sign for Qingdao Kingking Applied Chemistry you should be aware of.

儘管整個市場在十二個月中下跌了約25%,但青島金王應用化學股東的表現甚至更糟,跌幅爲33%。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨6%的總虧損。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。一個很好的例子:我們發現了你應該注意的青島金王應用化學的一個警告信號。

Of course Qingdao Kingking Applied Chemistry may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,青島金王應用化學可能不是最好的買入股票。因此,您可能希望看到這批免費的成長股。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論